tirzepatide lean mass loss muscle with Tirzepatide‐induced body composition changes: Implications from the SURPASS‐3 MRI substudy Weight loss and muscle loss. – Tirzepatide and Lost Muscle Mass

As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetite

Talking about the MariTide program, CFO Peter Griffith said CAPEX has been raised to about $1.3 billion in 2024, up 25% year-on-year

Although initially developed for oncology, PROTAC-based strategies are now being explored in cardiovascular disease, where selective degradation of pathogenic proteins could mitigate hypertrophy, fibrosis and heart failure progression

This can develop into a hardened, solid mass called a bezoar